-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Immunocore Holdings plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q2 2025.
- Immunocore Holdings plc Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $606K, a 59.2% decline year-over-year.
- Immunocore Holdings plc Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was -$2.03M, a 52.3% increase year-over-year.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2024 was -$1.85M, a 67% increase from 2023.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2023 was -$5.6M, a 148% decline from 2022.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2022 was $11.7M, a 7673% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)